Minerva Neurosciences, Inc. (NERV) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $4.72K; Additional Paid in Capital, Common StockUSD $583.43M; Retained Earnings (Accumulated Deficit)USD $-796.74M; Stockholders' Equity Attributable to ParentUSD $-213.30M.
- 2026-03-31: Common Stock, Value, IssuedUSD $4.38K; Additional Paid in Capital, Common StockUSD $560.19M; Retained Earnings (Accumulated Deficit)USD $-814.20M; Stockholders' Equity Attributable to ParentUSD $-254.01M.
- 2025-12-31: Common Stock, Value, IssuedUSD $4.33K; Additional Paid in Capital, Common StockUSD $548.05M; Retained Earnings (Accumulated Deficit)USD $-688.80M; Stockholders' Equity Attributable to ParentUSD $-140.75M.
- 2025-09-30: Common Stock, Value, IssuedUSD $699.00; Additional Paid in Capital, Common StockUSD $370.55M; Retained Earnings (Accumulated Deficit)USD $-405.13M; Stockholders' Equity Attributable to ParentUSD $-34.58M.
Minerva Neurosciences, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Stock Split USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.72K | $583.43M | $-796.74M | $-213.30M | 3 month · $2.27M | (m) | (m) | (m) |
| 2026-03-31 | $4.38K | $560.19M | $-814.20M | $-254.01M | 3 month · $8.71M | (m) | (m) | (m) |
| 2025-12-31 | $4.33K | $548.05M | $-688.80M | $-140.75M | 12 month · $1.33M | (m) | (m) | (m) |
| 2025-09-30 | $699.00 | $370.55M | $-405.13M | $-34.58M | 3 month · $272.90K | (m) | (m) | (m) |
| 2025-06-30 | $699.00 | $370.28M | $-402.39M | $-32.11M | 3 month · $298.22K | (m) | (m) | (m) |
| 2025-03-31 | $699.00 | $369.98M | $-399.13M | $-29.15M | 3 month · $297.23K | (m) | (m) | (m) |
| 2024-12-31 | $699.00 | $369.68M | $-395.38M | $-25.69M | 12 month · $1.33M | (m) | (m) | (m) |
| 2024-09-30 | $699.00 | $369.43M | $-391.10M | $-21.67M | 3 month · $307.71K | (m) | (m) | (m) |
| 2024-06-30 | $699.00 | $369.13M | $-413.62M | $-44.49M | 3 month · $329.32K | (m) | (m) | (m) |
| 2024-03-31 | $699.00 | $368.80M | $-405.38M | $-36.59M | 3 month · $438.85K | (m) | (m) | (m) |
| 2023-12-31 | $699.00 | $368.36M | $-396.82M | $-28.46M | 12 month · $1.97M | (m) | (m) | (m) |
| 2023-09-30 | $699.00 | $367.75M | $-387.79M | $-20.05M | 3 month · $371.94K | (m) | (m) | (m) |
| 2023-06-30 | $699.00 | $367.46M | $-379.97M | $-12.51M | 3 month · $608.91K | (m) | (m) | (m) |
| 2023-03-31 | $534.00 | $347.16M | $-373.78M | $-26.62M | 3 month · $376.46K | (m) | (m) | (m) |
| 2022-12-31 | $534.00 | $346.79M | $-366.81M | $-20.02M | 12 month · $4.11M | (m) | 12 month · $-5.00 | (m) |
| 2022-09-30 | $534.00 | $345.84M | $-360.08M | $-14.25M | 3 month · $1.04M | (m) | (m) | (m) |
| 2022-06-30 | $534.00 | $344.80M | $-353.18M | $-8.38M | 3 month · $1.07M | (m) | 3 month · $-5.00 | (m) |
| 2022-03-31 | $4.27K | $343.73M | $-344.47M | $-736.13K | 3 month · $1.05M | (m) | (m) | (m) |
| 2021-12-31 | $534.00 | $342.68M | $-334.70M | $7.98M | 12 month · $5.22M | (m) | (m) | (m) |
| 2021-09-30 | $4.27K | $341.47M | $-313.39M | $28.08M | 3 month · $1.11M | (m) | (m) | (m) |
| 2021-06-30 | $4.27K | $340.35M | $-304.19M | $36.17M | 3 month · $1.38M | (m) | (m) | (m) |
| 2021-03-31 | $4.27K | $338.97M | $-344.50M | $45.37M | 3 month · $1.52M | (m) | (m) | (m) |
| 2020-12-31 | $4.27K | $337.45M | $-284.80M | $52.66M | 12 month · $9.70M | (m) | (m) | (m) |
| 2020-09-30 | $4.27K | $335.49M | $-277.47M | $58.02M | 3 month · $2.06M | (m) | (m) | (m) |
| 2020-06-30 | $4.07K | $326.30M | $-304.20M | $56.94M | 3 month · $3.49M | (m) | (m) | (m) |
| 2020-03-31 | $3.92K | $317.51M | $-298.89M | $18.62M | 3 month · $2.20M | (m) | (m) | (m) |
| 2019-12-31 | $3.91K | $314.51M | $-286.74M | $27.78M | 12 month · $9.17M | (m) | (m) | (m) |
| 2019-09-30 | $3.90K | $312.34M | $-256.82M | $55.53M | 3 month · $2.22M | (m) | (m) | (m) |
| 2019-06-30 | $3.90K | $310.12M | $-242.86M | $67.27M | 3 month · $2.32M | (m) | (m) | (m) |
| 2019-03-31 | $3.90K | $307.80M | $-230.38M | $77.42M | 3 month · $2.46M | (m) | (m) | (m) |
| 2018-12-31 | $3.89K | $304.81M | $-214.55M | $90.26M | 12 month · $8.18M | (m) | (m) | (m) |
| 2018-09-30 | $3.88K | $302.74M | $-201.35M | $101.39M | 3 month · $2.26M 9 month · $6.27M | (m) | (m) | (m) |
| 2018-06-30 | $3.88K | $299.99M | $-189.33M | $110.66M | 3 month · $1.90M 6 month · $4.01M | (m) | (m) | (m) |
| 2018-03-31 | $3.88K | $298.09M | $-176.80M | $121.29M | 3 month · $2.11M | (m) | (m) | (m) |
| 2017-12-31 | $3.88K | $295.98M | $-164.38M | $131.60M | 12 month · $5.03M | (m) | (m) | (m) |
| 2017-09-30 | $3.87K | $294.72M | $-164.54M | $130.18M | 9 month · $3.78M | 9 month · $2.94M | (m) | (m) |
| 2017-06-30 | $3.68K | $251.31M | $-153.28M | $98.03M | 6 month · $2.54M | (m) | (m) | (m) |
| 2017-03-31 | $3.67K | $249.79M | $-143.50M | $106.29M | 3 month · $1.31M | (m) | (m) | (m) |
| 2016-12-31 | $3.50K | $238.84M | $-132.86M | $105.98M | 12 month · $3.57M | (m) | (m) | (m) |
| 2016-09-30 | $3.48K | $236.59M | $-123.45M | $113.14M | 9 month · $2.56M | (m) | (m) | (m) |
| 2016-06-30 | $3.48K | $235.63M | $-115.03M | $120.61M | 6 month · $1.62M | (m) | (m) | (m) |
| 2016-03-31 | $2.79K | $176.46M | $-109.82M | $66.65M | 3 month · $790.23K | (m) | (m) | (m) |
| 2015-12-31 | $2.47K | $157.13M | $-101.81M | $55.32M | 12 month · $2.20M | 12 month · $2.47M | (m) | 12 month · $166.34K |
| 2015-09-30 | $2.47K | $156.44M | $-93.37M | $63.07M | 9 month · $1.51M | 9 month · $2.47M | (m) | 9 month · $166.34K |
| 2015-06-30 | $2.47K | $155.81M | $-87.43M | $68.38M | 6 month · $882.30K | 6 month · $2.47M | (m) | 6 month · $166.34K |
| 2015-03-31 | $2.47K | $155.26M | $-80.82M | $74.44M | 3 month · $336.37K | (m) | (m) | 3 month · $166.34K |
| 2014-12-31 | $1.84K | $126.23M | $-74.73M | $51.50M | 12 month · $7.42M | (m) | (m) | (m) |
| 2014-09-30 | $1.84K | $124.00M | $-67.29M | $56.72M | 9 month · $5.18M | (m) | (m) | (m) |
| 2014-06-30 | $852.00 | $69.37M | $-40.13M | $29.23M | 6 month · $4.27M | (m) | (m) | (m) |
| 2013-12-31 | $611.00 | $38.01M | $-17.83M | $20.18M | 12 month · $423.19K | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | $19.02K | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |